Cargando…
Leveraging speech and artificial intelligence to screen for early Alzheimer’s disease and amyloid beta positivity
Early detection of Alzheimer’s disease is required to identify patients suitable for disease-modifying medications and to improve access to non-pharmacological preventative interventions. Prior research shows detectable changes in speech in Alzheimer’s dementia and its clinical precursors. The curre...
Autores principales: | Fristed, Emil, Skirrow, Caroline, Meszaros, Marton, Lenain, Raphael, Meepegama, Udeepa, Papp, Kathryn V, Ropacki, Michael, Weston, Jack |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9639797/ https://www.ncbi.nlm.nih.gov/pubmed/36381988 http://dx.doi.org/10.1093/braincomms/fcac231 |
Ejemplares similares
-
A remote speech‐based AI system to screen for early Alzheimer's disease via smartphones
por: Fristed, Emil, et al.
Publicado: (2022) -
Validation of a Remote and Fully Automated Story Recall Task to Assess for Early Cognitive Impairment in Older Adults: Longitudinal Case-Control Observational Study
por: Skirrow, Caroline, et al.
Publicado: (2022) -
Protocol for Rhapsody: a longitudinal observational study examining the feasibility of speech phenotyping for remote assessment of neurodegenerative and psychiatric disorders
por: Hampsey, Elliot, et al.
Publicado: (2022) -
Clinical Feasibility of Speech Phenotyping for Remote Assessment of Neurodegenerative and Psychiatric Disorders (RHAPSODY): a study protocol
por: Taylor, R., et al.
Publicado: (2022) -
Leveraging artificial intelligence to improve people’s planning strategies
por: Callaway, Frederick, et al.
Publicado: (2022)